# Varenicline Treatment for Cannabis Use Disorder

> **NCT02892110** · PHASE2 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 72 (actual)

## Conditions studied

- Substance Use Disorder

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02892110
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-13
- **Primary completion:** 2018-11-08
- **Final completion:** 2018-11-27
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2019-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02892110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02892110, "Varenicline Treatment for Cannabis Use Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02892110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*